摘要
目的:探讨血清β2微球蛋白(β2-m)、铁蛋白(SF)在非霍奇金淋巴瘤(NHL)诊治中的作用。方法:收集64例NHL患者的血清,采用免疫发光法荧光偏振免疫检测(FPIA)技术测定血清β2-m,采用化学发光免疫分析技术测定SF。结果:NHL患者血清β2-m、SF的升高与临床分期、化疗效果有关。结论:血清β2-m和SF可作为NHL患者临床诊断、化疗效果的辅助指标。
Objective To explore the significance of serum β2 microglobulin (β2-m) and serum ferritin (SF) in diagnosis and treatment of non-Hodskln lymphoma. Methods Serum was collected from 64 cases of patients with NHL, the serum β2-m was determined by fluorescence polarization immmloassay(FPIA) and the SF was measured by electrochemical immlmoassay chemiluminescence method. Results Elevation of the NHL patients' serum β2-m and SF showed closely related to clinical stages and effect of chemotherapy. Conclusion The serum β2-m and SF can be used as the auxiliary indexes for NHL patients' clinical diagnosis and chemotherapeutic effect.
出处
《放射免疫学杂志》
CAS
2013年第6期717-718,共2页
Journal of Radioimmanology